We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

130 hedge funds and large institutions have $823M invested in Select Medical in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 43 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more capital invested

Capital invested by funds: $534M → $823M (+$290M)

19% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 43

18% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 17

6.25% more ownership

Funds ownership: 87.48%93.73% (+6.3%)

2% more funds holding

Funds holding: 128130 (+2)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

82% less call options, than puts

Call options by funds: $565K | Put options by funds: $3.08M

Holders
130
Holders Change
+2
Holders Change %
+1.56%
% of All Funds
3.77%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
20
Increased
51
Reduced
43
Closed
17
Calls
$565K
Puts
$3.08M
Net Calls
-$2.52M
Net Calls Change
-$2.24M
Name Holding Trade Value Shares
Change
Change in
Stake
GT
101
Glenmede Trust
Pennsylvania
$220K -$673K -137,799 -80%
Tudor Investment Corp
102
Tudor Investment Corp
Connecticut
$187K -$578K -118,412 -80%
Nisa Investment Advisors
103
Nisa Investment Advisors
Missouri
$174K
Jane Street
104
Jane Street
New York
$173K +$135K +27,595 New
DCM
105
Dean Capital Management
Kansas
$171K +$63.3K +12,974 +91%
WCM
106
Wedge Capital Management
North Carolina
$158K -$36K -7,378 -23%
UBS AM
107
UBS AM
Illinois
$153K -$22.7K -4,640 -16%
SI
108
SII Investments
Wisconsin
$153K +$120K +24,499 New
Susquehanna International Group
109
Susquehanna International Group
Pennsylvania
$146K +$114K +23,324 New
PCM
110
Prelude Capital Management
New York
$122K -$49.8K -10,208 -34%
SCA
111
SAC Capital Advisors
Connecticut
$117K +$91.1K +18,653 New
U
112
UBS
Switzerland
$104K +$73.5K +15,061 +956%
Ohio Public Employees Retirement System (OPERS)
113
Ohio Public Employees Retirement System (OPERS)
Ohio
$95K +$49.4K +10,121 +198%
FQ
114
First Quadrant
California
$70K
Federated Hermes
115
Federated Hermes
Pennsylvania
$62K -$71.6K -14,666 -60%
TRCT
116
Tower Research Capital (TRC)
New York
$50K +$35.3K +7,231 +975%
BJ
117
BlackRock Japan
Japan
$45K -$13.6K -2,793 -28%
Ameriprise
118
Ameriprise
Minnesota
$28K -$21.7K -4,442 -51%
Teacher Retirement System of Texas
119
Teacher Retirement System of Texas
Texas
$18K -$34.5K -7,075 -71%
BlackRock
120
BlackRock
New York
$18K
TAM
121
Tocqueville Asset Management
New York
$18K +$14.3K +2,931 New
BG
122
BlackRock Group
United Kingdom
$12K
BNP Paribas Financial Markets
123
BNP Paribas Financial Markets
France
$9.47K -$116K -23,804 -94%
Royal Bank of Canada
124
Royal Bank of Canada
Ontario, Canada
$7K -$239K -49,042 -98%
CFN
125
Cordasco Financial Network
Florida
$6K +$4.53K +928 New

SEM Hedge Fund Activity: Q4 2013 in Review

130 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q4 2013, worth a combined $823M — up 54% from $534M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new SEM positions and 17 closed out — a net gain of 3 holders — while 51 added to existing stakes and 43 trimmed.

The largest buyer was Allianz Asset Management, adding an estimated $31.5M. The largest seller was Guggenheim Capital, exiting entirely with an estimated $10.5M sold.

  • 130 institutional investors held Select Medical (SEM) as of Q4 2013, up from 128 in Q3 2013.
  • Funds reported $823M of Select Medical stock for Q4 2013, up 54% quarter-over-quarter.
  • 20 funds opened new Select Medical positions in Q4 2013 and 17 closed out, a net change of +3 holders.
  • The largest Select Medical buyer in Q4 2013 was Allianz Asset Management, an estimated $31.5M added.
  • The largest Select Medical seller in Q4 2013 was Guggenheim Capital, an estimated $10.5M sold.

Based on aggregated 13F filings for Q4 2013.